Bill Anderson, Bayer CEO (Dia Dipasupil/Getty Images)
Bayer partners with RNA startup launched out of Dana-Farber
Even as Bayer continues cutting costs across its conglomerate, it’s still making some small R&D deals to add to its pipeline.
On Wednesday, the German …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
